InnaPhase Overview

  • Founded
  • 1998
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $65M
Latest Deal Amount

InnaPhase General Information

Description

Provider of laboratory information management systems for the pharmaceutical industry. The products are used in drug development laboratories and bioanalytical applications.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
  • 1601 Cherry Street
  • Suite 1200
  • Philadelphia, PA 19102
  • United States
+1 (215) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

InnaPhase Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 15-Sep-2004 $65M 000 0000 Completed Clinical Trials - General
1. Later Stage VC (Series D) 07-Jan-2003 000 000 Completed Clinical Trials - General
To view InnaPhase’s complete valuation and funding history, request access »

InnaPhase Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Edison Partners Venture Capital Minority 000 0000 000000 0
EuclidSR Partners Venture Capital Minority 000 0000 000000 0
LLR Partners PE/Buyout Minority 000 0000 000000 0
NewSpring Capital Growth/Expansion Minority 000 0000 000000 0
To view InnaPhase’s complete investors history, request access »